Literature DB >> 25808990

Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactions.

Mark Mellett1, Paola Atzei1, Ronan Bergin1, Alan Horgan1, Thomas Floss2, Wolfgang Wurst2, John J Callanan3, Paul N Moynagh4.   

Abstract

Receptor families of the innate immune response engage in 'cross-talk' to tailor optimal immune responses against invading pathogens. However, these responses are subject to multiple levels of regulation to keep in check aberrant inflammatory signals. Here, we describe a role for the orphan receptor interleukin-17 receptor D (IL-17RD) in negatively regulating Toll-like receptor (TLR)-induced responses. Deficiency of IL-17RD expression in cells leads to enhanced pro-inflammatory signalling and gene expression in response to TLR stimulation, and Il17rd(-/-) mice are more susceptible to TLR-induced septic shock. We demonstrate that the intracellular Sef/IL-17R (SEFIR) domain of IL-17RD targets TIR adaptor proteins to inhibit TLR downstream signalling thus revealing a paradigm involving cross-regulation of members of the IL-17R and TLR families.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808990     DOI: 10.1038/ncomms7669

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  16 in total

Review 1.  The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity.

Authors:  Xinyang Song; Xiao He; Xiaoxia Li; Youcun Qian
Journal:  Cell Mol Immunol       Date:  2016-03-28       Impact factor: 11.530

2.  Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy.

Authors:  Fay Wright; Marilyn Hammer; Steven M Paul; Bradley E Aouizerat; Kord M Kober; Yvette P Conley; Bruce A Cooper; Laura B Dunn; Jon D Levine; Gail DEramo Melkus; Christine Miaskowski
Journal:  Cytokine       Date:  2017-01-19       Impact factor: 3.861

Review 3.  Golgi Complex: A Signaling Hub in Cancer.

Authors:  Daniela Spano; Antonino Colanzi
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 4.  Feedback regulation of RTK signaling in development.

Authors:  Cynthia L Neben; Megan Lo; Natalia Jura; Ophir D Klein
Journal:  Dev Biol       Date:  2017-10-26       Impact factor: 3.582

5.  Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis.

Authors:  Tao He; Yan Huang; Chen Zhang; Denghui Liu; Chao Cheng; Weidong Xu; Xiaoling Zhang
Journal:  Oncotarget       Date:  2017-09-11

6.  The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.

Authors:  Nozomu Moriya; Seiji Shibasaki; Miki Karasaki; Tsuyoshi Iwasaki
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

Review 7.  Interleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling.

Authors:  Shivangi Pande; Xuehui Yang; Robert Friesel
Journal:  Cell Commun Signal       Date:  2021-01-12       Impact factor: 5.712

8.  Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis.

Authors:  Charlotte Girondel; Kim Lévesque; Marie-Josée Langlois; Sarah Pasquin; Marc K Saba-El-Leil; Nathalie Rivard; Robert Friesel; Marc J Servant; Jean-François Gauchat; Sylvie Lesage; Sylvain Meloche
Journal:  Oncogene       Date:  2020-11-11       Impact factor: 9.867

Review 9.  The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection.

Authors:  Yonghong Li; Chaojun Wei; Hui Xu; Jing Jia; Zhenhong Wei; Rui Guo; Yanjuan Jia; Yu Wu; Yuanting Li; Xiaoming Qi; Zhenhao Li; Xiaoling Gao
Journal:  Mediators Inflamm       Date:  2018-03-19       Impact factor: 4.711

10.  Common microRNA⁻mRNA Interactions in Different Newcastle Disease Virus-Infected Chicken Embryonic Visceral Tissues.

Authors:  Yan-Qing Jia; Xing-Long Wang; Xiang-Wei Wang; Chuan-Qi Yan; Chang-Jie Lv; Xiao-Qin Li; Zhi-Li Chu; Fathalrhman Eisa Addoma Adam; Sa Xiao; Shu-Xia Zhang; Zeng-Qi Yang
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.